Barclays Maintains Equal-Weight on Biogen, Raises Price Target to $230

Benzinga · 6d ago
Barclays analyst Emily Field maintains Biogen (NASDAQ:BIIB) with a Equal-Weight and raises the price target from $200 to $230.